TrialBritish journal of clinical pharmacology2017

Dynamic population pharmacokinetic-pharmacodynamic modelling and simulation supports similar efficacy in glycosylated haemoglobin response with once or twice-daily dosing of canagliflozin.

Willem de Winter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.